secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oruka Therapeutics, Inc. (ORKA)
CIK:        0000907654
Form:       8-K
Filed at:   2023-12-04T23:59:59+00:00
Accession:  0000950170-23-067790
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ARCA biopharma increases retention bonuses for two execs by 50% to $150,000 each
--------------------------------------------------------------------------------

- Retention bonus for Thomas Keuer and C. Jeffrey Dekker increased 50% to $150,000 each.
- Early payment of $35,000 on Dec 8, 2023, to assist with tax obligations on RSU vesting.
- Remaining $115,000 payable upon corporate transaction or board approval of clinical decisions.
- Eligibility requires continued employment in good standing through payment event dates.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/907654/000095017023067790/0000950170-23-067790-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/907654/000095017023067790/abio-20231129.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-067790

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer